GRID Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors

Sir Mortimer B. Davis - Jewish General Hospital

Status

Enrolling

Conditions

Patients With Symptomatic or Bulky Tumors (More Than 8 cm) or With Tumors Resistant to Radiation

Treatments

Radiation: spatially fractionated radiation therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT02333110

14-161

Details and patient eligibility

About

Palliative radiation therapy represents 40% of the on-going radiation at the Jewish General Hospital. In a traditional palliative radiation treatment to bulky or radioresistant tumors, radiotherapy schema varies from 24 to 30 Gys given in 3 to 10 fractions, depending on the tumor size, tumor location and tumor pathology. However, for many patients this treatment involves considerable toxicity, travel and time spent at the hospital. Spatially fractionated radiation (SFR) is an alternative technique that consists in delivering one single treatment, given through a grid containing holes. The present study is proposing to validate SFR as a safe and effective mean to palliate patients with symptomatic bulky tumors (more than 8 cm) or with tumors known to be resistant to radiation.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patient with histologically or cytologically confirmed malignancy. All malignant histologies/cytologies are eligible.
Patient with bulky tumor (larger than 8cm), or with a tumor known to be resistant to radiation (eg. Melanoma, hypernephroma, sarcoma), or with a tumor previously irradiated with a palliative intent requiring more than 1 fraction of radiation
Patient planned to undergo palliative radiation therapy treatments to one of the following 5 sites: extremities, neck, chest, abdomen and pelvis
WHO performance status of 0-2
Aged 18 years or older
Ability to sign and understand an informed consent form

Exclusion criteria